LEP, leptin, 3952

N. diseases: 931; N. variants: 15
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C3838754
Disease: Congenital leptin deficiency
Congenital leptin deficiency
0.100 AlteredExpression disease BEFREE Analysis of serum leptin levels and leptin gene mutations is a rapid and easy step toward the diagnosis of congenital leptin deficiency that is considered an important cause in early childhood obesity. 31483094 2020
CUI: C3838754
Disease: Congenital leptin deficiency
Congenital leptin deficiency
0.100 Biomarker disease BEFREE While leptin replacement therapy fails to provide substantial benefit in common obesity, it is an effective treatment for congenital leptin deficiency and states of acquired leptin deficiency such as lipodystrophy. 30475221 2019
CUI: C3838754
Disease: Congenital leptin deficiency
Congenital leptin deficiency
0.100 Biomarker disease BEFREE Congenital Leptin Deficiency and Leptin Gene Missense Mutation Found in Two Colombian Sisters with Severe Obesity. 31067764 2019
CUI: C3838754
Disease: Congenital leptin deficiency
Congenital leptin deficiency
0.100 AlteredExpression disease BEFREE To test this assumption, we examined ambulatory blood pressure, resting heart rate, Schellong test results, cold pressor test results, heart rate variability, catecholamine metabolites, and aldosterone levels in 6 patients with congenital leptin deficiency before as well as 2-7 days and 7-14 months after the start of leptin substitution. 31357197 2019
CUI: C3838754
Disease: Congenital leptin deficiency
Congenital leptin deficiency
0.100 Biomarker disease BEFREE A cohort of n = 21 children living in Germany or Austria with monogenic obesity due to congenital leptin deficiency (group LEP, n = 6), leptin receptor deficiency (group LEPR, n = 6) and primarily heterozygous MC4 receptor deficiency (group MC4R, n = 9) was analyzed. 29568105 2018
CUI: C3838754
Disease: Congenital leptin deficiency
Congenital leptin deficiency
0.100 Biomarker disease BEFREE Leptin therapy reverses morbid obesity related to congenital leptin deficiency and appears to possibly treat lipodystrophy, a finding which has led to the approval of leptin for the treatment of lipodystrophy in the USA and Japan. 26313897 2015
CUI: C3838754
Disease: Congenital leptin deficiency
Congenital leptin deficiency
0.100 AlteredExpression disease BEFREE In addition to congenital leptin deficiency, conditions that may be associated with decreased leptin levels include hypothalamic amenorrhea, anorexia nervosa, and congenital or acquired lipodystrophy syndromes. 22665330 2012
CUI: C3838754
Disease: Congenital leptin deficiency
Congenital leptin deficiency
0.100 GeneticVariation disease BEFREE We studied three adults with congenital leptin deficiency due to a mutation in the leptin gene. 21613360 2011
CUI: C3838754
Disease: Congenital leptin deficiency
Congenital leptin deficiency
0.100 GeneticVariation disease BEFREE We have identified five Turkish patients (one male and two female adults; one boy and one girl) with congenital leptin deficiency due to a missense mutation in the leptin gene. 21410864 2011
CUI: C3838754
Disease: Congenital leptin deficiency
Congenital leptin deficiency
0.100 Biomarker disease BEFREE Congenital leptin deficiency: diagnosis and effects of leptin replacement therapy. 21340154 2010
CUI: C3838754
Disease: Congenital leptin deficiency
Congenital leptin deficiency
0.100 GeneticVariation disease BEFREE Congenital leptin deficiency due to homozygosity for the Delta133G mutation: report of another case and evaluation of response to four years of leptin therapy. 15472169 2004
CUI: C3838754
Disease: Congenital leptin deficiency
Congenital leptin deficiency
0.100 Biomarker disease BEFREE I have shown that administration of recombinant human leptin results in the onset of puberty at an appropriate developmental age in human congenital leptin deficiency. 12087499 2002
CUI: C3838754
Disease: Congenital leptin deficiency
Congenital leptin deficiency
0.100 Biomarker disease BEFREE Treatment with recombinant human leptin (0.028 mg/kg) induced a progressive weight loss (without evidence of tachyphylaxis) in a morbidly obese patient with congenital leptin deficiency. 11469718 2001